Navigation Links
Olympus Unveils New Dissolvable Post Sinus Surgery Products
Date:1/5/2012

CENTER VALLEY, Pa., Jan. 5, 2012 /PRNewswire/ -- Olympus, a precision technology leader in designing and delivering innovative solutions in Medical and Surgical Products, among other core businesses, today announced the addition of a broad line of advanced, dissolvable sinus spacing and hemostat products to its already extensive ENT product portfolio. These products include spacers, foams and powders available in either plant-based or chitosan polysaccharide polymers.

Through a distribution partnership with Hemostasis, LLC, the plant-based and chitosan compositions have been formulated to improve post sinus surgery recovery, comfort and healing. All products are biocompatible, dissolve naturally, require no mixing or special storage considerations and are easily conformed to fit nasal anatomy. Additionally, the sinus products minimize edema, bleeding and prevent post operative adhesions by maintaining space between the upper chambers of the nasal cavities.  

"The new offerings extend Olympus' current world-class ENT solutions to surgeons performing sinus and anterior skull base procedures and their patients," commented Perry Mykleby, Vice President of Marketing for Olympus' ENT sales. "We are pleased to collaborate with Hemostasis, a high-quality medical device manufacturer partner, to enhance patient care."

"Hemostasis is committed to providing the most comprehensive, technologically advanced ENT sinus spacing and hemostat technologies that are safe and effective for their intended use," said Hemostasis' President, Keith Roberts. "Working directly with leading physicians, we have developed practical technologies designed to optimize physician usability and efficacy, which ultimately have improved procedure outcomes and enhances overall patient care."

About Olympus Medical Systems ENT Business
Olympus develops procedure solutions for healthcare professionals that help improve outcomes and enhance quality of life for their patients. Our ENT Business offers advanced visualization and treatment products for Rhinology, Pediatric ENT, Laryngology, Otology, Sleep and Head and Neck procedures. Products include endoscopy and video; powered electrosurgical and manual instruments, middle ear prosthetics, and vent (PE) tubes.

For more information about Olympus America, visit www.olympusamerica.com.
For more information about ENT products, click here.

About Hemostasis, LLC
Hemostasis is a dynamic company committed to developing and marketing innovative technologies for the rapidly changing demands of the global medical industry. We work directly with leading physicians to develop practical products that are designed to optimize usability and efficacy for medical professionals, improve procedure outcomes and enhance overall patient care. www.hemostasisllc.com.


'/>"/>
SOURCE Olympus America
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Omnyx Licenses Olympus Digital Pathology Patents
2. Olympus America Licenses Digital Pathology Patents to BioImagene, Inc.
3. Olympus Launches 2011 National Innovation Awards Program
4. Stryker Announces Definitive Agreement to Sell OP-1 for Use in Orthopaedic Bone Applications to Olympus
5. Stryker Completes Sale of OP-1 for use in Orthopaedic Bone Applications to Olympus
6. Gumz to Retire as President and CEO of Olympus Corporation of the Americas
7. Olympus Biotech Names Oliver Burckhardt to President North America
8. Olympus Introduces Worlds First Autoclavable 5mm HD Deflectable Videolaparoscope
9. Olympus Introduces New Peracetic Acid Solution for Rapid High-Level Disinfection
10. Olympus Broadens Portfolio With a Suite of New Single-Use Aspiration Needles
11. Oregon Tourism Commission Unveils New Online Customer Service Training Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... , Jan. 17, 2017  Jazz Pharmaceuticals plc (Nasdaq: ... patient has been enrolled in a Phase 3 clinical ... best supportive care (BSC) in the prevention of hepatic ... hematopoietic stem cell transplant (HSCT) who are at high ... The defibrotide clinical trial will be conducted across approximately ...
(Date:1/17/2017)... , Jan. 17, 2017  Market Research Future published a ... Devices Market is expected to reach USD 33.6 million during the ... Market Highlights ... The Global Endoscopy Devices Market has been examined as a swiftly ... there is huge demand for endoscopy device in various regions.  The ...
(Date:1/17/2017)... 17, 2017 Following an initial analysis, ... the Food and Drug Administration,s (FDA,s) final regulatory ... Products by Pharmacies and Outsourcing Facilities." In its ... on pre-packaging -- which would have put patients ... long term care (LTC) pharmacies.  ...
Breaking Medicine Technology:
(Date:1/17/2017)... Utah (PRWEB) , ... January 17, 2017 , ... ... of accredited, online continuing education for EMS and firefighting professionals, has released four ... (VILT) Solution. These new courses are taught live in an online classroom and ...
(Date:1/17/2017)... ... ... Neil H. Greco Insurance Agency, a northern New Jersey firm that provides asset ... charity drive to raise awareness of heart disease and promote habits that improve heart ... responsible for 1 in every 4 deaths at the national level each year. In ...
(Date:1/17/2017)... NJ (PRWEB) , ... January 17, 2017 , ... ... personality, and breast cancer survivor Sandra Lee as keynote speaker for the 34th ... Beach, Florida. , In making the announcement, PER® president, Phil Talamo, said, “We ...
(Date:1/17/2017)... NJ (PRWEB) , ... January 17, 2017 , ... ... Learning Center and the Montclair State University’s Athletic Training Education program forged a ... University’s Athletic Training Education Program, which is consists of both student members ...
(Date:1/16/2017)... ... January 16, 2017 , ... Etymotic ... groundbreaking GunSport•PRO® and EB15•LE® electronic earplugs at the NSSF SHOT Show on January ... #2809. The SHOT Show is the shooting, hunting and outdoor trade show and ...
Breaking Medicine News(10 mins):